The company’s latest report states that key drivers of this growth include the rising prevalence of degenerative spinal conditions due to the increasing aging population and the system’s advantages over traditional spinal fusion procedures, including motion preservation.
“Future adoption of pedicle screw-based dynamic stabilization systems is highly dependent on the procurement of clinical efficacy data demonstrating support for device utilization," explained Jennifer Ryan, healthcare analyst for GlobalData. “This is because, despite generating great enthusiasm upon their introduction to the market, pedicle screw-based dynamic stabilization systems have attracted concern over the long-term clinical efficacy of these devices, with reports emerging of devices loosening and failing. As such, spinal fusion remains the gold standard treatment for patients with degenerative spinal disorders.”
In terms of key players, the pedicle screw-based dynamic stabilization systems market is fairly consolidated, with the majority of players consisting of well-established orthopedic and spine companies. Zimmer Biomet’s Dynesys system is the principal player worldwide, and systems from Globus Medical and Paradigm Spine are also highly utilized.
“Lingering questions about the clinical effectiveness of these pedicle screw-based dynamic systems is a major setback threatening the continued adoption of currently marketed devices," Ryan said. "GlobalData believes the use of clinical trials focused on efficacy will be an important factor in the future of pedicle-screw based dynamic stabilization systems’ adoption and reimbursement.”
In terms of individual countries, China represented the largest portion of the market in 2016, holding just over 40 percent of the regional revenue, and is expected to maintain this dominance throughout the forecast period. India is expected to be the fastest-growing market through 2023, at a CAGR of 7.9 percent while the slowest growth will be observed will be observed in New Zealand at a CAGR of 3.7 percent.
Four-thousand of the world’s largest companies, including over 70 percent of FTSE 100 and 60 percent of Fortune 100 companies, leverage GlobalData’s information, expert analysis, and solutions. GlobalData helps clients decode the future across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.